Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW 12,630
+10 (0.08%)
At close: Sep 19, 2025
Cell Biotech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 47,456 | 49,913 | 53,787 | 50,526 | 46,873 | 45,582 | Upgrade |
Other Revenue | - | - | - | -0 | - | - | Upgrade |
| 47,456 | 49,913 | 53,787 | 50,526 | 46,873 | 45,582 | Upgrade | |
Revenue Growth (YoY) | -12.28% | -7.20% | 6.46% | 7.79% | 2.83% | -0.82% | Upgrade |
Cost of Revenue | 13,315 | 14,102 | 15,139 | 12,854 | 11,399 | 11,309 | Upgrade |
Gross Profit | 34,141 | 35,811 | 38,649 | 37,672 | 35,475 | 34,273 | Upgrade |
Selling, General & Admin | 21,270 | 21,847 | 29,845 | 25,278 | 21,988 | 24,639 | Upgrade |
Research & Development | 4,294 | 4,332 | 3,725 | 3,559 | 3,500 | 3,329 | Upgrade |
Other Operating Expenses | 213.95 | 226.87 | 221.45 | 249.55 | 207.87 | 179.76 | Upgrade |
Operating Expenses | 28,282 | 29,015 | 36,453 | 31,621 | 28,218 | 30,606 | Upgrade |
Operating Income | 5,859 | 6,796 | 2,195 | 6,051 | 7,257 | 3,667 | Upgrade |
Interest Expense | -47.19 | -60.88 | -61.95 | -37.49 | -42.48 | -49.28 | Upgrade |
Interest & Investment Income | 2,903 | 3,112 | 3,180 | 860.17 | 1,103 | 700.01 | Upgrade |
Earnings From Equity Investments | - | - | -82.2 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -561.12 | 5,093 | 698.5 | 2,990 | 3,325 | -2,246 | Upgrade |
Other Non Operating Income (Expenses) | 123.59 | 84.34 | 1,162 | 309.01 | 306.97 | 372.3 | Upgrade |
EBT Excluding Unusual Items | 8,277 | 15,024 | 7,092 | 10,173 | 11,950 | 2,444 | Upgrade |
Gain (Loss) on Sale of Investments | 1,075 | 575.56 | -211.19 | - | 111.68 | -50.69 | Upgrade |
Gain (Loss) on Sale of Assets | 73.26 | 10.14 | -0.26 | -0.91 | 29.05 | 9.48 | Upgrade |
Pretax Income | 9,426 | 15,610 | 6,880 | 10,172 | 12,090 | 2,402 | Upgrade |
Income Tax Expense | -686 | 483.01 | 576.36 | 1,891 | 1,707 | -786.7 | Upgrade |
Net Income | 10,112 | 15,127 | 6,304 | 8,281 | 10,383 | 3,189 | Upgrade |
Net Income to Common | 10,112 | 15,127 | 6,304 | 8,281 | 10,383 | 3,189 | Upgrade |
Net Income Growth | -22.02% | 139.97% | -23.87% | -20.25% | 225.58% | -55.90% | Upgrade |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade |
Shares Change (YoY) | - | - | -0.73% | -2.50% | -0.32% | -4.25% | Upgrade |
EPS (Basic) | 1477.47 | 2210.25 | 921.07 | 1201.04 | 1468.32 | 449.56 | Upgrade |
EPS (Diluted) | 1477.23 | 2210.00 | 921.00 | 1201.00 | 1468.00 | 449.56 | Upgrade |
EPS Growth | -22.02% | 139.96% | -23.31% | -18.19% | 226.54% | -53.94% | Upgrade |
Free Cash Flow | 9,736 | 18,138 | 6,264 | 10,445 | 14,044 | 6,485 | Upgrade |
Free Cash Flow Per Share | 1422.63 | 2650.25 | 915.24 | 1515.03 | 1985.94 | 914.17 | Upgrade |
Dividend Per Share | 450.000 | 450.000 | 450.000 | 450.000 | 450.000 | 450.000 | Upgrade |
Dividend Growth | - | - | - | - | - | -25.00% | Upgrade |
Gross Margin | 71.94% | 71.75% | 71.85% | 74.56% | 75.68% | 75.19% | Upgrade |
Operating Margin | 12.35% | 13.62% | 4.08% | 11.98% | 15.48% | 8.04% | Upgrade |
Profit Margin | 21.31% | 30.31% | 11.72% | 16.39% | 22.15% | 7.00% | Upgrade |
Free Cash Flow Margin | 20.52% | 36.34% | 11.65% | 20.67% | 29.96% | 14.23% | Upgrade |
EBITDA | 9,585 | 10,668 | 6,100 | 9,689 | 11,046 | 7,352 | Upgrade |
EBITDA Margin | 20.20% | 21.37% | 11.34% | 19.18% | 23.57% | 16.13% | Upgrade |
D&A For EBITDA | 3,726 | 3,872 | 3,904 | 3,638 | 3,789 | 3,685 | Upgrade |
EBIT | 5,859 | 6,796 | 2,195 | 6,051 | 7,257 | 3,667 | Upgrade |
EBIT Margin | 12.35% | 13.62% | 4.08% | 11.98% | 15.48% | 8.04% | Upgrade |
Effective Tax Rate | - | 3.09% | 8.38% | 18.59% | 14.12% | - | Upgrade |
Advertising Expenses | - | 5,249 | 11,977 | 9,134 | 6,632 | 6,817 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.